These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 29990562

  • 1. Chronic iron overload induces vascular dysfunction in resistance pulmonary arteries associated with right ventricular remodeling in rats.
    Bertoli SR, Marques VB, Rossi EM, Krause M, Carneiro MTWD, Simões MR, Dos Santos L.
    Toxicol Lett; 2018 Oct 01; 295():296-306. PubMed ID: 29990562
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.
    Naito Y, Hosokawa M, Sawada H, Oboshi M, Iwasaku T, Okuhara Y, Eguchi A, Nishimura K, Soyama Y, Hirotani S, Mano T, Ishihara M, Masuyama T.
    Heart Vessels; 2016 Dec 01; 31(12):2074-2079. PubMed ID: 27311944
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sex-dependent remodeling of right ventricular function in a rat model of pulmonary arterial hypertension.
    Kwan ED, Hardie BA, Garcia KM, Mu H, Wang TM, Valdez-Jasso D.
    Am J Physiol Heart Circ Physiol; 2024 Aug 01; 327(2):H351-H363. PubMed ID: 38847755
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.
    Naito Y, Hosokawa M, Hao H, Sawada H, Hirotani S, Iwasaku T, Okuhara Y, Eguchi A, Hirota S, Ohyanagi M, Tsujino T, Masuyama T.
    Biochem Biophys Res Commun; 2013 Jun 28; 436(2):145-51. PubMed ID: 23707944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
    Bueno-Beti C, Sassi Y, Hajjar RJ, Hadri L.
    Methods Mol Biol; 2018 Jun 28; 1816():233-241. PubMed ID: 29987824
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chronic iron overload in rats increases vascular reactivity by increasing oxidative stress and reducing nitric oxide bioavailability.
    Marques VB, Nascimento TB, Ribeiro RF, Broseghini-Filho GB, Rossi EM, Graceli JB, dos Santos L.
    Life Sci; 2015 Dec 15; 143():89-97. PubMed ID: 26523985
    [Abstract] [Full Text] [Related]

  • 17. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP, Okida A, Higuchi M, Yamano Y, Hikasa Y.
    Vascul Pharmacol; 2018 Jan 15; 100():41-50. PubMed ID: 29100963
    [Abstract] [Full Text] [Related]

  • 18. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
    Nguyen QT, Nsaibia MJ, Sirois MG, Calderone A, Tardif JC, Fen Shi Y, Ruiz M, Daneault C, Gagnon L, Grouix B, Laurin P, Dupuis J.
    Cardiovasc Res; 2020 Jan 01; 116(1):171-182. PubMed ID: 30753422
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of Pulmonary Hypertension With Angiotensin II Receptor Blocker and Neprilysin Inhibitor Sacubitril/Valsartan.
    Clements RT, Vang A, Fernandez-Nicolas A, Kue NR, Mancini TJ, Morrison AR, Mallem K, McCullough DJ, Choudhary G.
    Circ Heart Fail; 2019 Nov 01; 12(11):e005819. PubMed ID: 31707802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.